350 related articles for article (PubMed ID: 27055785)
1. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
2. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.
Chen Y; Li T; Li J; Mo Z
Int J Biol Markers; 2015 Feb; 30(1):e12-21. PubMed ID: 25262700
[TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase Gene Polymorphism (Val158Met) and Development of Pre-eclampsia.
Taravati A; Tohidi F; Moniri M; Kamali K
Arch Med Res; 2017 Feb; 48(2):180-186. PubMed ID: 28625321
[TBL] [Abstract][Full Text] [Related]
5. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
[TBL] [Abstract][Full Text] [Related]
6. The association between COMT Val158Met gene polymorphism and antipsychotic-induced tardive dyskinesia risk.
Lv Z; Rong B; Tong X; Li X; Chen X; Wang X; Li Z
Int J Neurosci; 2016 Nov; 126(11):1044-50. PubMed ID: 26398367
[TBL] [Abstract][Full Text] [Related]
7. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Xiao L; Tong M; Jin Y; Huang W; Li Z
Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092
[TBL] [Abstract][Full Text] [Related]
8. Potential Impact of
Mir R; Bhat M; Javid J; Jha C; Saxena A; Banu S
J Cardiovasc Dev Dis; 2018 Jul; 5(3):. PubMed ID: 30011860
[No Abstract] [Full Text] [Related]
9. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Tan X; Chen M
Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
[TBL] [Abstract][Full Text] [Related]
10. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
11. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
12. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
Zhang H; Zhang Z; Wu J; Xu Y; Cheng R; Li L
Urol Int; 2013; 91(2):213-9. PubMed ID: 23257985
[TBL] [Abstract][Full Text] [Related]
14. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.
Liu J; Chen P; Guo M; Lu L; Li L
Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
Kumar P; Rai V
Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
[TBL] [Abstract][Full Text] [Related]
16. The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population.
Tian C; Liu L; Yang X; Wu H; Ouyang Q
Tumour Biol; 2014 Apr; 35(4):3003-8. PubMed ID: 24307619
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
[TBL] [Abstract][Full Text] [Related]
18. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).
Feng Y; Zhao X; Zhou C; Yang L; Liu Y; Bian C; Gou J; Lin X; Wang Z; Zhao X
Gene; 2013 Oct; 529(2):296-9. PubMed ID: 23939469
[TBL] [Abstract][Full Text] [Related]
19. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
Su M; Song Y
Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
[TBL] [Abstract][Full Text] [Related]
20. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
